Form D — ECM Therapeutics, Inc.
0001743104-25-000002 · filed 2025-10-10
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $40,000,000
- Total sold
- $35,219,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- ECM Therapeutics, Inc.
- CIK
- 1743104
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 118 MARSHALL DRIVE
WARRENDALE, PA 15086 - Phone
- 724-242-7106
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Paul F. Fagan · Executive OfficerWarrendale, PA Find on LinkedIn ↗
-
Stephen Badylak · Executive OfficerWarrendale, PA Find on LinkedIn ↗
-
Katie Collins · Executive OfficerWarrendale, PA Find on LinkedIn ↗
-
Jenna Dziki · Executive OfficerWarrendale, PA Find on LinkedIn ↗
-
George Hussey · Executive OfficerWarrendale, PA Find on LinkedIn ↗
-
Christine Sheehy · Executive OfficerWarrendale, PA Find on LinkedIn ↗
-
Lindsey Saldin · Executive OfficerWarrendale, PA Find on LinkedIn ↗
View original on SEC EDGAR.